MDMA-Assisted Therapy for Pathological Narcissism

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 27, 2024

Primary Completion Date

August 15, 2026

Study Completion Date

January 31, 2027

Conditions
Narcissism
Interventions
DRUG

midomafetamine (MDMA)-Assisted Therapy

This treatment consists 3 Preparation sessions followed by 3 Experimental sessions at 4-week intervals; after each Experimental session, 3 weekly Integration sessions will be conducted. For the first Experimental Session, the dose of MDMA is 80 mg; for the second and third Experimental Sessions, the dose of MDMA is 120 mg. For all three Experimental sessions, a supplemental dose of 50% of the initial dose will be available. The Preparation, Experimental, and Integration Sessions will involve psychotherapy developed specifically for this trial and population.

Trial Locations (1)

98195

RECRUITING

University of Washington, Seattle

All Listed Sponsors
lead

University of Washington

OTHER